Management of peripheral vascular disease

被引:55
作者
Baumgartner, I [1 ]
Schainfeld, R
Graziani, L
机构
[1] Univ Hosp Bern, Div Angiol, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland
[2] Tufts Univ, Sch Med, Div Vasc Med, St Elizabeths Med Ctr, Boston, MA 02111 USA
[3] Ist Clin Citta Brescia, Serv Emodinam, I-25100 Brescia, Italy
来源
ANNUAL REVIEW OF MEDICINE | 2005年 / 56卷
关键词
ankle-brachial index; atherothrombosis; epidemiology; gene therapy; limb ischemia;
D O I
10.1146/annurev.med.56.082103.104649
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The management of patients with peripheral arterial occlusive disease (PAD) has to be planned in the context of natural history, epidemiology, and apparent risk factors that predict deterioration. The ankle-brachial index to date has proved to be the most effective, accurate, and practical method of PAD detection. Given that PAD is a powerful indicator of systemic atherosclerosis and (independent of symptoms) is associated with an increased risk of myocardial infarction and stroke, as well as a six times greater likelihood of death, the prevalence and demographic distribution of measurable PAD becomes particularly relevant. Reliable information on interventions to confer symptom relief is much weaker and reflects discrepancies between published reports from centers of excellence and the experience of patients routinely treated in communities around the world. The impact of newer treatment modalities, such as complex endovascular procedures and therapeutic angiogenesis, has been a subject of recent controversy.
引用
收藏
页码:249 / 272
页数:24
相关论文
共 104 条
[71]  
Murabito JM, 1997, CIRCULATION, V96, P44
[72]   Ankle-arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health study [J].
Newman, AB ;
Shemanski, L ;
Manolio, TA ;
Cushman, M ;
Mittelmark, M ;
Polak, JF ;
Powe, NR ;
Siscovick, D .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :538-545
[73]   PROSTACYCLIN FOR ISCHEMIC ULCERS IN PERIPHERAL ARTERIAL-DISEASE - A RANDOM ASSIGNMENT, PLACEBO CONTROLLED-STUDY [J].
NIZANKOWSKI, R ;
KROLIKOWSKI, W ;
BIELATOWICZ, J ;
SZCZEKLIK, A .
THROMBOSIS RESEARCH, 1985, 37 (01) :21-28
[74]   Peripheral arterial disease [J].
Ouriel, K .
LANCET, 2001, 358 (9289) :1257-1264
[75]   In memoriam: Ethel Jean Finck, MD: 1932-2003 [J].
Pentecost, MJ .
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2003, 14 (12) :1489-1490
[76]   Aortic and lower-extremity arterial disease: Evaluation with MR angiography versus conventional angiography [J].
Quinn, SF ;
Sheley, RC ;
Semonsen, KG ;
Leonardo, VJ ;
Kojima, K ;
Szumowski, J .
RADIOLOGY, 1998, 206 (03) :693-701
[77]   CONSERVATIVE MANAGEMENT OF INTERMITTENT CLAUDICATION [J].
RADACK, K ;
WYDERSKI, RJ .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (02) :135-146
[78]   BETA-ADRENERGIC BLOCKER THERAPY DOES NOT WORSEN INTERMITTENT CLAUDICATION IN SUBJECTS WITH PERIPHERAL ARTERIAL-DISEASE - A METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS [J].
RADACK, K ;
DECK, C .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (09) :1769-1776
[79]   Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease - A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication [J].
Rajagopalan, S ;
Mohler, ER ;
Lederman, RJ ;
Mendelsohn, FO ;
Saucedo, JF ;
Goldman, CK ;
Blebea, J ;
Macko, J ;
Kessler, PD ;
Rasmussen, HS ;
Annex, BH .
CIRCULATION, 2003, 108 (16) :1933-1938
[80]   Adenovirus-mediated gene transfer of VEGF121 improves lower-extremity endothelial function and flow reserve [J].
Rajagopalan, S ;
Shah, M ;
Luciano, A ;
Crystal, R ;
Nabel, EG .
CIRCULATION, 2001, 104 (07) :753-755